Shareholders Equity: The sum of preferred and common equity items.
LB Pharmaceuticals Inc (LBRX) had Shareholders Equity of $332.35M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-51.60M |
|
-- |
|
-- |
|
$53.91M |
|
$-53.91M |
|
$2.31M |
|
$-51.60M |
|
$-51.60M |
|
$-51.60M |
|
$-51.60M |
|
$-51.60M |
|
$-51.60M |
|
$-53.91M |
|
$-53.89M |
|
30.14M |
|
30.14M |
|
$-1.71 |
|
$-1.71 |
|
| Balance Sheet Financials | |
$355.30M |
|
$2.20M |
|
$6.39M |
|
$361.69M |
|
$23.56M |
|
-- |
|
$5.78M |
|
$29.34M |
|
$332.35M |
|
$332.35M |
|
|
Shareholders Equity |
$332.35M |
28.68M |
|
| Cash Flow Statement Financials | |
$-60.92M |
|
$0.06M |
|
$93.81M |
|
$250.94M |
|
$283.89M |
|
$32.95M |
|
$7.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-61.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.53% |
|
-15.53% |
|
-14.27% |
|
-15.53% |
|
$11.59 |
|
$-2.03 |
|
$-2.02 |
|